Tyra Biosciences and Johnson & Johnson are pursuing their own approaches to treating a common, early-stage form of bladder ...

(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder cancer and only modestly extended the lives of previously treated patients with late-stage lung ...

Over the decades, scientists have revealed many strategies our cells use to keep normal cells from becoming cancerous. Now, Fred Hutchinson Cancer Center scientists have discovered a completely ...

In May, surgeons at USC and UCLA collaborated to perform the world’s first-in-human bladder transplant. Currently, when a bladder fails or needs to be removed, doctors create a “neobladder” using a ...

June 27 (Reuters) - Aquinox Pharmaceuticals Inc said on Wednesday its treatment for bladder pain syndrome failed to meet the main goal of a late-stage trial, and the company plans to stop developing ...

Over the decades, scientists have revealed many strategies that keep normal cells from becoming cancerous. Understanding natural anti-tumor processes could help researchers develop better approaches ...